.. Australian researchers develop West Nile virus treatment A University of Queensland researcher is rolling out the world’s first particular immunotherapy item using monoclonal antibodies for the potentially lethal West Nile virus, which in turn causes seasonal epidemics around the world. The mosquito-borne virus impacts the central anxious systems of humans, horses and birds in THE UNITED STATES, Africa, the center Europe and East. Dr Roy Hall, from UQ’s College of Molecular and Microbial Sciences, is rolling out an immunotherapy treatment for the condition predicated on a monoclonal antibody that binds to the benign Australian Kunjin virus. Related StoriesMedStar Washington Hospital Middle's Ebola Response Team recognized with 2015 Patient Basic safety AwardUC Irvine Health experts develop one-step check to detect HCV infectionsBlocking calcium-signaling pathway could inhibit Ebola virus and other resources of deadly infectionsThe treatment completely neutralised the West Nile virus and provided infected mice security against the starting point of symptoms, according to Dr Hall.COTI selected for Canadian lifestyle sciences partnering mission Critical Outcome Technologies Inc. announced today that the business was chosen by the Consulate General of Canada and BIOTECanada to wait a existence sciences partnering objective in Boston, MA. Wayne Danter, Chief Executive Officer , and Mr. Michael Barr, Vice President of Business Marketing and Development. The aim of these meetings can be to provide detailed scientific details on COTI-2 also to discuss licensing possibilities, as COTI-2 continues its development towards a Phase 1 clinical trial in 2011. Wayne Danter, CEO of COTI. Pristima's unique, end-to-end answer for the management of preclinical data from compound receipt through research submission is distinguishable from its competition and will serve as the foundation for the CTI's rapid expansion.